NCT03386799

Brief Summary

Power assisted wheelchairs have specific advantages compared to manual propelled or powered Wheelchair. Autonomad Mobility has developed a new device (DUO), the assistance being triggered by the motion of the wheelchair and not an push on the hand rim, people who use their foot to move or people pushing the wheelchair can be helped by the device as people propelling the wheelchair with their arms. Furthermore DUO has an option with a longer assistance (AEP+) which can be preferred by some people. To be referenced and reimbursed by the French health insurance, DUO has to be compared with an other power assistance device for wheelchairs, already referenced. The study is a comparative study between DUO and the ALBER E Motion. Each patient is his own control and is assessed in 4 experimental conditions, with intervals of 3 or 4 days, manually propelled, with the E mtion device, with the DUO device and the single push configuration, with the DUO device and the AEP+ configuration. The main outcome measure will be the user's satisfaction (using 8 items of the ESAT questionnaire)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 18, 2017

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 29, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

March 20, 2018

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 21, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 21, 2021

Completed
Last Updated

July 12, 2022

Status Verified

July 1, 2022

Enrollment Period

3.1 years

First QC Date

December 18, 2017

Last Update Submit

July 11, 2022

Conditions

Keywords

Power assistance deviceWheelchair

Outcome Measures

Primary Outcomes (1)

  • ESAT questionnaire

    User satisfaction, using 8 items of the ESAT (Echelle de Satisfaction envers une Aide Technique) questionnaire

    at 12 days

Secondary Outcomes (5)

  • Success rate during the indoor test (wheelchair skill program)

    at 12 days

  • Time to perform the wheelchair skill program

    at 12 days

  • Time run

    at 12 days

  • Maximal heart rate

    at 12 days

  • Effort assessment by the Borg scale

    at 12 days

Study Arms (1)

Patient in wheelchair

Patient in wheelchair with E-motion device

Device: E-motion device

Interventions

Powered assisted Wheelchair with the E-motion device. Outdoor and indoor runs

Patient in wheelchair

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient with a motor deficiency (of any origin) needing a manual wheelchair

You may qualify if:

  • with a motor deficiency (of any origin) needing a manual wheelchair
  • propelling his wheelchair with both arms or with one foot and one arm.
  • covered by the French national health insurance.
  • living at less than 30km form the investigation center

You may not qualify if:

  • subject of a guardianship or tutelage measure
  • owning already a power wheelchair or a powered assisted wheelchair
  • with cognitive impairments that affect the steering capacity or the understanding of the instructions.
  • Patient unable to use a manual wheelchair indoor without help,
  • Contraindication in keeping a seating position especially the occurrence of ulcers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Swynghedauw, CHU

Lille, France

Location

MeSH Terms

Conditions

ParaplegiaHemiplegia

Condition Hierarchy (Ancestors)

ParalysisNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • André Thevenon, MD,PhD

    University Hospital, Lille

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 18, 2017

First Posted

December 29, 2017

Study Start

March 20, 2018

Primary Completion

April 21, 2021

Study Completion

April 21, 2021

Last Updated

July 12, 2022

Record last verified: 2022-07

Locations